Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis

The Laryngoscope(2024)10.1002/lary.31438Source: DataRank Database

Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis is a research paper published in The Laryngoscope (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.70)OA: hybridTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (39)

Christine Liu ORCID,Jonathan B. Overdevest ORCID,Anna C. Zemke ORCID,Aastha Khatiwada ORCID,David A. Gudis ORCID

Live enrichment

PubMed:38634358 PMC:PMC11305934 OpenAlex:https://openalex.org/W4394918411

Cystic Fibrosis Foundation

Grant: BESWIC20A0

Cystic Fibrosis Foundation

Grant: BESWIC22Y5

Cystic Fibrosis Foundation

Grant: TAYLOR19A0

Cystic Fibrosis Foundation

Grant: ZEMKE19A0

National Institute on Deafness and Other Communication Disorders

Grant: R25DC020151

NIDCD NIH HHS

Grant: K23 DC019678

Marshall and Margherite McComb Foundation

FWCI

3.70

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/lary.31438

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/lary.31438

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.31438

journalhttps://doi.org/10.1002/lary.31438

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38634358

Fields of Study

Sinusitis and nasal conditionsCystic Fibrosis Research AdvancesOlfactory and Sensory Function StudiesHumansCystic FibrosisSinusitisFemaleMaleAdultRhinitisProspective StudiesChronic DiseaseSino-Nasal Outcome TestMinimal Clinically Important DifferenceTreatment OutcomeAminophenolsSeverity of Illness IndexYoung AdultMiddle AgedQuinolonesCystic Fibrosis Transmembrane Conductance Regulator

MeSH Terms

Minimal Clinically Important DifferenceSino-Nasal Outcome TestAdultAminophenolsChronic DiseaseCystic FibrosisFemaleHumansMaleMiddle AgedProspective StudiesRhinitisSeverity of Illness IndexSinusitisQuinolonesTreatment OutcomeCystic Fibrosis Transmembrane Conductance RegulatorYoung Adult

Keywords

Cystic fibrosisMedicineInternal medicineChronic RhinosinusitisMinimal Clinically Important DifferenceCftr Modulator TherapyElexacaftor/Tezacaftor/Ivacaftor

Sustainable Development Goals

SDG 0: Good health and well-being